Sustained delivery of large molecules such as antibodies may be attractive, because not only anti-VEGF therapy and anti-TNFα antibody have shown excellent results in the treatment of refractory eye diseases (such as Behcet's disease), although this regimen also requires repeated cycles of therapy [36], [37]. This evidence concerns the gene TNF and eye disorder.